Bio-Techne Corp (TECH): Price and Financial Metrics

Bio-Techne Corp (TECH): $64.42

0.88 (-1.35%)

POWR Rating

Component Grades








Add TECH to Watchlist
Sign Up

Industry: Biotech




#58 of 345

in industry

TECH Price/Volume Stats

Current price $64.42 52-week high $89.91
Prev. close $65.30 52-week low $51.79
Day low $64.32 Volume 110,677
Day high $65.27 Avg. volume 1,012,642
50-day MA $63.20 Dividend yield 0.5%
200-day MA $74.91 Market Cap 10.19B

TECH Stock Price Chart Interactive Chart >


  • TECH scores best on the Quality dimension, with a Quality rank ahead of 81.81% of US stocks.
  • TECH's strongest trending metric is Growth; it's been moving up over the last 177 days.
  • TECH's current lowest rank is in the Momentum metric (where it is better than 19.42% of US stocks).

TECH Stock Summary

  • The price/operating cash flow metric for BIO-TECHNE CORP is higher than 90.99% of stocks in our set with a positive cash flow.
  • With a price/sales ratio of 8.93, BIO-TECHNE CORP has a higher such ratio than 88.58% of stocks in our set.
  • With a year-over-year growth in debt of 60.9%, BIO-TECHNE CORP's debt growth rate surpasses 87.84% of about US stocks.
  • Stocks that are quantitatively similar to TECH, based on their financial statements, market capitalization, and price volatility, are MMSI, ALGN, LMAT, STAA, and BDC.
  • TECH's SEC filings can be seen here. And to visit BIO-TECHNE CORP's official web site, go to

TECH Valuation Summary

  • TECH's EV/EBIT ratio is 35.4; this is 178.74% higher than that of the median Healthcare stock.
  • Over the past 243 months, TECH's price/sales ratio has gone down 1.1.

Below are key valuation metrics over time for TECH.

Stock Date P/S P/B P/E EV/EBIT
TECH 2023-11-20 8.8 5.0 40.8 35.4
TECH 2023-11-17 8.4 4.8 39.1 34.0
TECH 2023-11-16 8.4 4.8 39.0 33.9
TECH 2023-11-15 8.4 4.8 39.0 33.9
TECH 2023-11-14 8.3 4.8 38.7 33.6
TECH 2023-11-13 7.9 4.5 36.6 31.9

TECH Growth Metrics

    The year over year net cashflow from operations growth rate now stands at 25.33%.
  • The 5 year net cashflow from operations growth rate now stands at 67.75%.
  • Its year over year revenue growth rate is now at 26.96%.
Over the past 70 months, TECH's revenue has gone up $578,653,000.

The table below shows TECH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 1,119.84 296.31 261.823
2022-09-30 1,117.535 332.919 291.991
2022-06-30 1,105.599 325.272 272.051
2022-03-31 1,076.399 344.575 225.487
2021-12-31 1,029.575 346.313 210.53
2021-09-30 984.552 334.589 176.631

TECH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TECH has a Quality Grade of B, ranking ahead of 82.49% of graded US stocks.
  • TECH's asset turnover comes in at 0.44 -- ranking 101st of 682 Pharmaceutical Products stocks.
  • URGN, TMBR, and CRIS are the stocks whose asset turnover ratios are most correlated with TECH.

The table below shows TECH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.440 0.680 0.188
2021-03-31 0.412 0.673 0.250
2020-12-31 0.392 0.666 0.240
2020-09-30 0.376 0.662 0.330
2020-06-30 0.372 0.654 0.302
2020-03-31 0.387 0.660 0.271

TECH Price Target

For more insight on analysts targets of TECH, see our TECH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $549.60 Average Broker Recommendation 1.36 (Strong Buy)

Bio-Techne Corp (TECH) Company Bio

Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The company was founded in 1976 and is based in Minneapolis, Minnesota.

TECH Latest News Stream

Event/Time News Detail
Loading, please wait...

TECH Latest Social Stream

Loading social stream, please wait...

View Full TECH Social Stream

Latest TECH News From Around the Web

Below are the latest news stories about BIO-TECHNE CORP that investors may wish to consider to help them evaluate TECH as an investment opportunity.

Should You Hold Bio-Techne Corporation (TECH) For the Long Term?

Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund outperformed the Russell 2000 Growth Index. The Information Technology and Healthcare sectors contributed to the fund’s relative performance in the quarter, […]

Yahoo | December 1, 2023


Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, and Kim Kelderman, Chief Operating Officer will present at the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29, 2023, at 2:10 p.m. EST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at

Yahoo | November 27, 2023

Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)

Key Insights Bio-Techne's estimated fair value is US$57.87 based on 2 Stage Free Cash Flow to Equity With US$63.58...

Yahoo | November 23, 2023


Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

Yahoo | November 13, 2023


Bio-Techne Corporation (NASDAQ:TECH) today announced that Asuragen, a Bio-Techne brand, will present new data on clinical laboratory testing solutions related to cystic fibrosis variant detection, cancer monitoring, resolving conventionally inaccessible, disease-causing genes, and more at the upcoming meeting of the Association for Molecular Pathology (AMP), to be held November 14-18 in Salt Lake City, Utah. Attendees can learn about Asuragen's new products and innovations through a series of co

Yahoo | November 2, 2023

Read More 'TECH' Stories Here

TECH Price Returns

1-mo 9.86%
3-mo -14.57%
6-mo -18.56%
1-year -21.67%
3-year -15.02%
5-year 64.23%
YTD -21.93%
2022 -35.68%
2021 63.40%
2020 45.40%
2019 52.67%
2018 12.60%

TECH Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full TECH Dividend History

Continue Researching TECH

Want to see what other sources are saying about BIO-TECHNE Corp's financials and stock price? Try the links below:

BIO-TECHNE Corp (TECH) Stock Price | Nasdaq
BIO-TECHNE Corp (TECH) Stock Quote, History and News - Yahoo Finance
BIO-TECHNE Corp (TECH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!